Company Intelligence
LabGenius
LabGenius provides enterprise-grade artificial intelligence solutions, delivering specialized LabGenius Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- London, United Kingdom
- Website
- labgeniustx.com
- Founded
- 2012
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
LabGenius is a Healthcare AI company based in London, United Kingdom, founded in 2012.
London antibody discovery company combining EVA machine-learning platform with robotic experimentation for multispecific therapeutic antibodies.
Verified founder profile on Brel: James Field.
What it does
Through the deployment of LabGenius Platform, LabGenius provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
LabGenius Platform
Why It Matters
LabGenius provides enterprise-grade artificial intelligence solutions, delivering specialized LabGenius Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
LabGenius — Biotechnology
Explore LabGenius — Biotechnology by LabGenius. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Founders
People linked to this company in the Brel founder graph.
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
LabGenius
Industry
Industries served
- Biotechnology
Products
Capabilities
EVA integrates ML-driven protein engineering with synthetic biology and robotic automation — closing the design-build-test-learn loop inside LabGenius facilities rather than outsourcing…
Features
- EVA discovery platform integrating machine learning, robotic automation, and synthetic biology to design and optimize mul
- LGTX-101
- pharma partnership programs
Integrations
- Product and AI capabilities
- EVA integrates ML-driven protein engineering with synthetic biology and robotic automation — closing the design-build-test-learn loop inside LabGenius facilities rather than outsourcing validation to CRO timelines measured in quarters.
Country
Use cases
Related companies
Official Resources
Official and developer links on file for this company.
Latest Developments
Verified developments and timeline notes on file.
Partnerships
- June 18, 2026: LabGenius announced LG Chem research collaboration for AI/ML-designed tumour-targeting antibody.
- 2025: ESMO IO poster for Nectin-4 x CD3 T-cell engager; expanded Sanofi collaboration on antibody optimisation.
Frequently Asked Questions
What does LabGenius do?
LabGenius specializes in artificial intelligence, developing LabGenius Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is LabGenius based and when was it founded?
LabGenius is based in United Kingdom and was founded in 2012.
What are the main products offered by LabGenius?
The flagship platform from LabGenius is LabGenius Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of LabGenius?
LabGenius primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.